Minocycline-based Therapy for Carbapenem-resistant Acinetobacter baumannii Pneumonia: a Multicenter Retrospective Study
Abstract
BACKGROUND
Minocycline is one of the few antibiotics that remain highly effective against carbapenem-resistant Acinetobacter baumannii (CRAB). However, the efficacy of minocycline for treating CRAB pneumonia has not been clearly demonstrated yet.
METHODS
This multicenter retrospective cohort study evaluated adults treated for CRAB pneumonia at three tertiary care hospitals in South Korea from 2017 to 2022. Patients who received antibiotic regimens including minocycline were compared to those who received regimens not containing minocycline. The primary outcome measure was a 14-day clinical success. Multiple logistic regression with overlap weighting was conducted to compare the risk for outcome measures between the two groups.
RESULTS
Among 411 patients (175 in the minocycline-included group and 236 in the minocycline-excluded group), the minocycline group had higher 14-day clinical success (57.1% vs. 34.3%, adjusted odds ratio [aOR]: 4.06, 95% confidence interval [CI]: 1.56-10.54, P=0.004) and lower 28-day mortality (aOR: 0.27, 95% CI: 0.09-0.79, P=0.016). The minocycline group was associated with longer mechanical ventilator-free days (aOR: 4.0 d, 95% CI: 2.1-6.0, P<0.001) without increase of nephrotoxicity or hepatotoxicity. Consistent results were observed in subgroup analyses for patients who stayed in the ICU, those who received colistin, and elderly patients.
CONCLUSION
Minocycline-based combination therapy demonstrated better outcomes than regimens without…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 411 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.